Does Dr. NANDA KERKAR have financial conflicts of interest?

Dr. NANDA KERKAR (M.D.) has received a total of $47,988 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $47,988 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. NANDA KERKAR?

According to CMS Open Payments data, Dr. NANDA KERKAR received funding from MIRUM PHARMACEUTICALS ($23,440), ALEXION PHARMACEUTICALS ($14,554), and OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION ($5,463).

Does Dr. NANDA KERKAR receive research grants or speaking fees?

Dr. NANDA KERKAR has received $47,988 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. NANDA KERKAR

M.D.Real-Time Hydrated

Specialty: Pediatrics, Pediatric Gastroenterology

Practice Location: ROCHESTER, NY 14642

NPI Number: 1841251139

LIFETIME INDUSTRY VALUE

$47,988

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. KERKAR is a verified Pediatrics, Pediatric Gastroenterology practitioner based in ROCHESTER, NY.

Between 2021 and 2025, Dr. KERKAR had an overall industry promotional and research financial footprint of $47,988 as recorded in the federal CMS Open Payments database.

$47,988 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. KERKAR's primary funding source is MIRUM PHARMACEUTICALS, which accounts for $23,440 (representing 48.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MIRUM PHARMACEUTICALS

Rank 1

$23,440

48.8%

ALEXION PHARMACEUTICALS

Rank 2

$14,554

30.3%

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION

Rank 3

$5,463

11.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.